Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
34.15
+0.65 (1.94%)
At close: Feb 11, 2026

TPEX:7427 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1,4671,4842,5621,823936-
Market Cap Growth
6.36%-42.09%40.55%94.83%--
Enterprise Value
9758842,0631,731777-
Last Close Price
34.1532.2960.9752.0933.38-
PS Ratio
823.58880.65528.303376.081485.29-
PB Ratio
2.602.344.796.594.49-
P/TBV Ratio
2.732.455.076.987.81-
EV/Sales Ratio
-524.33425.313205.061233.73-
Debt / Equity Ratio
0.020.020.03---
Asset Turnover
0.000.000.010.000.00-
Inventory Turnover
0.240.15----
Quick Ratio
28.9126.7729.9520.565.7912.64
Current Ratio
30.3227.4330.4720.875.8012.67
Return on Equity (ROE)
-14.21%-17.97%-15.04%-27.68%-21.80%-33.34%
Return on Assets (ROA)
-8.88%-11.51%-9.68%-16.58%-12.83%-17.66%
Return on Capital Employed (ROCE)
-16.10%-17.60%-12.10%-24.90%-17.50%-24.80%
Earnings Yield
-5.98%-7.07%-2.38%-3.68%-3.83%-
FCF Yield
-5.43%-5.32%-2.26%-4.23%-3.63%-
Buyback Yield / Dilution
-12.53%-13.60%-50.23%-14.54%-33.09%-16.83%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.